{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:06:37Z","timestamp":1784167597910,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"DOI":"10.1007\/s11845-026-04552-3","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:57:33Z","timestamp":1784167053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperandrogenism and polycystic ovary syndrome phenotypes in idiopathic intracranial hypertension"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4166-9881","authenticated-orcid":false,"given":"Didem","family":"Sava\u015fc\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2024-1181","authenticated-orcid":false,"given":"H\u00fclya Erta\u015fo\u011flu","family":"Toydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4525-5125","authenticated-orcid":false,"given":"Murat","family":"Ekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-0898","authenticated-orcid":false,"given":"Vildan Ay\u015fe","family":"Yayla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"4552_CR1","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1212\/01.WNL.0000029570.69134.1B","volume":"59","author":"DI Friedman","year":"2002","unstructured":"Friedman DI, Jacobson DM (2002) Diagnostic criteria for idiopathic intracranial hypertension. Neurology 59:1492\u20131495. https:\/\/doi.org\/10.1212\/01.WNL.0000029570.69134.1B","journal-title":"Neurology"},{"key":"4552_CR2","doi-asserted-by":"publisher","first-page":"A2","DOI":"10.1136\/jnnp-2019-abn.48","volume":"90","author":"S Mollan","year":"2019","unstructured":"Mollan S, Aguiar M, Evision F et al (2019) TM3-2 The expanding burden of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 90:A2. https:\/\/doi.org\/10.1136\/jnnp-2019-abn.48","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4552_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jns.2004.05.009","volume":"223","author":"JA Galvin","year":"2004","unstructured":"Galvin JA, Van Stavern GP (2004) Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center. J Neurol Sci 223:157\u2013160. https:\/\/doi.org\/10.1016\/j.jns.2004.05.009","journal-title":"J Neurol Sci"},{"key":"4552_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/01658107.2017.1334218","volume":"42","author":"C Hornby","year":"2018","unstructured":"Hornby C, Botfield H, O\u2019Reilly MW et al (2018) Evaluating the fat distribution in idiopathic intracranial hypertension using dual-energy X-ray absorptiometry scanning. Neuroophthalmology 42:99\u2013104. https:\/\/doi.org\/10.1080\/01658107.2017.1334218","journal-title":"Neuroophthalmology"},{"key":"4552_CR5","doi-asserted-by":"publisher","first-page":"116940","DOI":"10.1016\/j.lfs.2019.116940","volume":"236","author":"J Wang","year":"2019","unstructured":"Wang J, Wu D, Guo H, Li M (2019) Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. Life Sci 236:116940. https:\/\/doi.org\/10.1016\/j.lfs.2019.116940","journal-title":"Life Sci"},{"key":"4552_CR6","doi-asserted-by":"publisher","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M (2020) Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab 35:100937. https:\/\/doi.org\/10.1016\/j.molmet.2020.01.001","journal-title":"Mol Metab"},{"key":"4552_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","volume":"92","author":"CJ Glueck","year":"2019","unstructured":"Glueck CJ, Goldenberg N (2019) Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics. Metabolism 92:108\u2013120. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.002","journal-title":"Metabolism"},{"key":"4552_CR8","doi-asserted-by":"publisher","first-page":"e125348","DOI":"10.1172\/jci.insight.125348","volume":"4","author":"MW O\u2019Reilly","year":"2019","unstructured":"O\u2019Reilly MW, Westgate CSJ, Hornby C et al (2019) A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight 4:e125348. https:\/\/doi.org\/10.1172\/jci.insight.125348","journal-title":"JCI Insight"},{"key":"4552_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jocn.2021.11.029","volume":"95","author":"MTM Wang","year":"2022","unstructured":"Wang MTM, Bhatti MT, Danesh-Meyer HV (2022) Idiopathic intracranial hypertension: Pathophysiology, diagnosis and management. J Clin Neurosci 95:172\u2013179. https:\/\/doi.org\/10.1016\/j.jocn.2021.11.029","journal-title":"J Clin Neurosci"},{"key":"4552_CR10","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1210\/jc.2016-3285","volume":"102","author":"MW O\u2019Reilly","year":"2017","unstructured":"O\u2019Reilly MW, Kempegowda P, Jenkinson C et al (2017) 11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome. J Clin Endocrinol Metab 102:840\u2013848. https:\/\/doi.org\/10.1210\/jc.2016-3285","journal-title":"J Clin Endocrinol Metab"},{"key":"4552_CR11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.17219\/acem\/61987","volume":"26","author":"D Szydlarska","year":"2017","unstructured":"Szydlarska D, Machaj M, Jakimiuk A (2017) History of discovery of polycystic ovary syndrome. Adv Clin Exp Med 26:555\u2013558. https:\/\/doi.org\/10.17219\/acem\/61987","journal-title":"Adv Clin Exp Med"},{"key":"4552_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W et al (2016) Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 106:6\u201315. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.003","journal-title":"Fertil Steril"},{"key":"4552_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.trsl.2006.05.003","volume":"148","author":"CJ Glueck","year":"2006","unstructured":"Glueck CJ, Golnik KC, Aregawi D et al (2006) Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia. Transl Res 148:215\u2013222. https:\/\/doi.org\/10.1016\/j.trsl.2006.05.003","journal-title":"Transl Res"},{"key":"4552_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.lab.2004.09.011","volume":"145","author":"CJ Glueck","year":"2005","unstructured":"Glueck CJ, Aregawi D, Goldenberg N et al (2005) Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia. J Lab Clin Med 145:72\u201382. https:\/\/doi.org\/10.1016\/j.lab.2004.09.011","journal-title":"J Lab Clin Med"},{"key":"4552_CR15","doi-asserted-by":"publisher","first-page":"e1968","DOI":"10.1212\/WNL.0000000000201064","volume":"99","author":"NJ Adderley","year":"2022","unstructured":"Adderley NJ, Subramanian A, Perrins M et al (2022) Headache, opiate use, and prescribing trends in women with idiopathic intracranial hypertension. Neurology 99:e1968\u2013e1978. https:\/\/doi.org\/10.1212\/WNL.0000000000201064","journal-title":"Neurology"},{"key":"4552_CR16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/ceo.14256","volume":"51","author":"M Thaller","year":"2023","unstructured":"Thaller M, Homer V, Mollan SP, Sinclair AJ (2023) Asymptomatic idiopathic intracranial hypertension: Prevalence and prognosis. Clin Exp Ophthalmol 51:598\u2013606. https:\/\/doi.org\/10.1111\/ceo.14256","journal-title":"Clin Exp Ophthalmol"},{"key":"4552_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/01658107.2022.2162089","volume":"47","author":"M Thaller","year":"2023","unstructured":"Thaller M, Adderley NJ, Subramanian A et al (2023) Co-morbid polycystic ovarian syndrome with idiopathic intracranial hypertension. Neuroophthalmology 47:49\u201352. https:\/\/doi.org\/10.1080\/01658107.2022.2162089","journal-title":"Neuroophthalmology"},{"key":"4552_CR18","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.50.4.1094","volume":"50","author":"MJ Kupersmith","year":"1998","unstructured":"Kupersmith MJ, Gamell L, Turbin R et al (1998) Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 50:1094\u20131098. https:\/\/doi.org\/10.1212\/WNL.50.4.1094","journal-title":"Neurology"},{"key":"4552_CR19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S0015-0282(01)03202-2","volume":"77","author":"CJ Glueck","year":"2002","unstructured":"Glueck CJ, Wang P, Kobayashi S et al (2002) Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 77:520\u2013525. https:\/\/doi.org\/10.1016\/S0015-0282(01)03202-2","journal-title":"Fertil Steril"},{"key":"4552_CR20","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.fertnstert.2007.04.043","volume":"89","author":"D Panidis","year":"2008","unstructured":"Panidis D, Farmakiotis D, Rousso D et al (2008) Obesity, weight loss, and the polycystic ovary syndrome: Effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Fertil Steril 89:899\u2013906. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.04.043","journal-title":"Fertil Steril"},{"key":"4552_CR21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/ped.12266","volume":"56","author":"SH Shin","year":"2014","unstructured":"Shin SH, Kim YM, Kim HY et al (2014) Idiopathic intracranial hypertension associated with polycystic ovarian syndrome. Pediatr Int 56:734\u2013736. https:\/\/doi.org\/10.1111\/ped.12266","journal-title":"Pediatr Int"},{"key":"4552_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000466685","volume":"9","author":"AM Albarrak","year":"2017","unstructured":"Albarrak AM, Kojan S (2017) Uncommon presentation of idiopathic intracranial hypertension in a patient with polycystic ovary syndrome: A case report. Case Rep Neurol 9:24\u201328. https:\/\/doi.org\/10.1159\/000466685","journal-title":"Case Rep Neurol"},{"key":"4552_CR23","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1093\/humrep\/der302","volume":"26","author":"SJ Liang","year":"2011","unstructured":"Liang SJ, Hsu CS, Tzeng CR et al (2011) Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40. Hum Reprod 26:3443\u20133449. https:\/\/doi.org\/10.1093\/humrep\/der302","journal-title":"Hum Reprod"},{"key":"4552_CR24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.yfrne.2014.04.002","volume":"35","author":"AV Roland","year":"2014","unstructured":"Roland AV, Moenter SM (2014) Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: Insight from animal models. Front Neuroendocrinol 35:494\u2013511. https:\/\/doi.org\/10.1016\/j.yfrne.2014.04.002","journal-title":"Front Neuroendocrinol"},{"key":"4552_CR25","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3390\/diagnostics13091559","volume":"13","author":"D Fahs","year":"2023","unstructured":"Fahs D, Salloum D, Nasrallah M et al (2023) Polycystic ovary syndrome: Pathophysiology and controversies in diagnosis. Diagnostics 13:1559. https:\/\/doi.org\/10.3390\/diagnostics13091559","journal-title":"Diagnostics"},{"key":"4552_CR26","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1210\/en.2014-1196","volume":"155","author":"ASL Caldwell","year":"2014","unstructured":"Caldwell ASL, Middleton LJ, Jimenez M et al (2014) Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology 155:3146\u20133159. https:\/\/doi.org\/10.1210\/en.2014-1196","journal-title":"Endocrinology"},{"key":"4552_CR27","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1210\/en.2014-1887","volume":"156","author":"ASL Caldwell","year":"2015","unstructured":"Caldwell ASL, Eid S, Kay CR et al (2015) Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization. Endocrinology 156:1441\u20131452. https:\/\/doi.org\/10.1210\/en.2014-1887","journal-title":"Endocrinology"},{"key":"4552_CR28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0889-8529(05)70077-3","volume":"28","author":"RS Rittmaster","year":"1999","unstructured":"Rittmaster RS (1999) Antiandrogen treatment of polycystic ovary syndrome. Endocrinol Metab Clin North Am 28:409\u2013421. https:\/\/doi.org\/10.1016\/S0889-8529(05)70077-3","journal-title":"Endocrinol Metab Clin North Am"},{"key":"4552_CR29","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1210\/en.2017-03218","volume":"159","author":"GE Ryan","year":"2018","unstructured":"Ryan GE, Malik S, Mellon PL (2018) Antiandrogen treatment ameliorates reproductive and metabolic phenotypes in the letrozole-induced mouse model of PCOS. Endocrinology 159:1734\u20131747. https:\/\/doi.org\/10.1210\/en.2017-03218","journal-title":"Endocrinology"},{"key":"4552_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2045-8118-11-10","volume":"11","author":"T Brinker","year":"2014","unstructured":"Brinker T, Stopa E, Morrison J et al (2014) A new look at cerebrospinal fluid circulation. Fluids Barriers CNS 11:10. https:\/\/doi.org\/10.1186\/2045-8118-11-10","journal-title":"Fluids Barriers CNS"},{"key":"4552_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12031-008-9157-4","volume":"38","author":"CH Alves","year":"2009","unstructured":"Alves CH, Gon\u00e7alves I, Socorro S et al (2009) Androgen receptor is expressed in murine choroid plexus and downregulated by 5\u03b1-dihydrotestosterone in male and female mice. J Mol Neurosci 38:41\u201349. https:\/\/doi.org\/10.1007\/s12031-008-9157-4","journal-title":"J Mol Neurosci"},{"key":"4552_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.yfrne.2016.12.002","volume":"44","author":"CRA Santos","year":"2017","unstructured":"Santos CRA, Duarte AC, Quintela T et al (2017) The choroid plexus as a sex hormone target: Functional implications. Front Neuroendocrinol 44:103\u2013121. https:\/\/doi.org\/10.1016\/j.yfrne.2016.12.002","journal-title":"Front Neuroendocrinol"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04552-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-026-04552-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04552-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:57:34Z","timestamp":1784167054000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-026-04552-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":32,"alternative-id":["4552"],"URL":"https:\/\/doi.org\/10.1007\/s11845-026-04552-3","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Commitee of Bak\u0131rk\u00f6y Dr. Sadi Konuk Research and Training Hospital (reference: 2020\/100).","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}